DR info

Clinical trials : 39 / Drugs : 38 - (DrugBank : 7) / Drug target genes : 27 - Drug target pathways : 95

Fibrodysplasia ossificans progressiva and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
272	Fibrodysplasia ossificans progressiva
6	Parkinson disease
140	Dorabe syndrome
13	Multiple sclerosis/Neuromyelitis optica
144	Lennox-Gastaut syndrome
193	Prader-Willi syndrome
298	Hereditary pancreatitis
70	Spinal stenosis
156	Rett syndrome
97	Ulcerative colitis
152	PCDH19 related syndrome
96	Crohn disease
201	Angelman syndrome
205	Fragile X syndrome related disease
145	West syndrome
22	Moyamoya disease
155	Acquired aphasia with convulsive disorder
2	Amyotrophic lateral sclerosis
231	Alpha-1-antitrypsin deficiency
158	Tuberous sclerosis
8	Huntington disease
34	Neurofibromatosis
98	Eosinophilic gastrointestinal disease
296	Biliary atresia
18	Spinocerebellar degeneration
21	Mitochondrial disease
36	Epidermolysis bullosa
3	Spinal muscular atrophy
206	Fragile X syndrome
46	Malignant rheumatoid arthritis
17	Multiple system atrophy
75	Cushing disease
5	Progressive supranuclear palsy
84	Sarcoidosis
58	Hypertrophic cardiomyopathy
67	Polycystic kidney disease
167	Marfan syndrome
81	Congenital adrenal hyperplasia
51	Scleroderma
86	Pulmonary arterial hypertension